United States – October 17, 2026 -- Digital Diagnostics says its LumineticsCore system avoided 91% of unnecessary specialty visits in a pivotal clinical trial and cut time-to-follow-up for positive patients from 60 days to 5 days. The company made the claims in AdvaMed's "The Insight Series: AI & Digital Health," speaking through Jacque Engle, Vice President of Marketing & Communication, and Juli Goldstein, Vice President of Government Affairs & Market Access.

United States – October 17, 2026 -- Three-quarters of medical technology companies surveyed by AdvaMed report memory chip constraints, and 88 percent have seen price increases, as data-center demand squeezes supply of components used in 75 percent to 80 percent of medtech products (excluding personal protective equipment and consumables).

Boston – October 17, 2026 -- AdvaMed will host The MedTech Conference October 18–21 in Boston, with programming across more than seven stages and over 20 focus areas and a keynote panel of three medtech chief executives.

Three medtech CEOs headline the featured keynote discussion

The featured session, "Pulse of Medtech: Where the Industry Is Going Next," brings together Mick Farrell of Resmed, Mike Mahoney of Boston Scientific and Ashley McEvoy of Insulet. John Babitt of EY will moderate.

United States – October 17, 2026 -- Nearly half of all heart attacks occur in patients classified as low risk under traditional factors such as age, cholesterol and family history, Elucid CEO Kelly Huang said in AdvaMed's "Insight Series: AI & Digital Health," arguing that AI must change clinical decisions rather than accelerate existing ones.

Boston – October 17, 2026 -- The MedTech Conference, running October 18–21 in Boston, will include 65 early- and mid-stage companies from the 2026 MedTech Innovator cohort, chosen from more than 1,800 applicants, alongside a program that makes digital health a core thread of the event, according to AdvaMed Digital Health Tech's new executive director.

Boston – October 17, 2026 -- AdvaMed is steering its more than 400 small and emerging medtech members toward The MedTech Conference, October 18–21 in Boston, where it expects over 4,000 attendees and 1,800 companies.

JC Scott, who has returned to the trade association as Chief Strategy Officer, also leads AdvaMed Accel as Executive Director. Accel is the association's dedicated division for emerging members, offering advocacy, access and community.

Boston – October 17, 2026 -- The MedTech Conference (#MTC26) in Boston this October will host its first dedicated gathering for chief medical officers, open to CMOs at AdvaMed member companies, according to Bobby Patrick, AdvaMed's SVP of Government Affairs.

Boston – October 17, 2026 -- AdvaMed's The MedTech Conference, set for October 18–21, 2026, will host its largest Medtech Campus to date, with 185+ presenting companies and more than 500 speakers across Campus and education sessions. The trade body reports member participation at an all-time high and says nearly half of registered attendees are new to the event.

United States – October 17, 2026 -- AdvaMed has told the U.S. Copyright Office that software built to diagnose, configure and service a medical device is a distinct product and should not be treated like the software that operates the device.